Lineage Cell Therapeutics, Inc. (LCTX) earnings
Quarterly results of Lineage Cell Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Lineage Cell Therapeutics, Inc. was expected to report around November 5, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Lineage Cell Therapeutics, Inc. reported revenue of $1.1M (-61.3% on the same quarter a year earlier) and net income of $1.5M.
Diluted earnings per share were -$0.03.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $1.1M | -61.3% | $1.5M | -$0.03 |
| Q1 FY2026 | $1.7M | +14.8% | -$4.8M | -$0.03 |
| Q4 FY2025 | $6.6M | +130.4% | $851K | - |
| Q3 FY2025 | $3.7M | -2.6% | -$29.8M | -$0.13 |
| Q2 FY2025 | $2.8M | - | -$30.5M | -$0.13 |
| Q1 FY2025 | $1.5M | - | -$4.1M | -$0.02 |
| Q4 FY2024 | $2.9M | - | -$3.3M | - |
| Q3 FY2024 | $3.8M | - | -$3M | -$0.02 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Annual report 10-K
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
When is Lineage Cell Therapeutics, Inc.'s next earnings date?
Lineage Cell Therapeutics, Inc. was expected to report around November 5, 2026; nothing is on file with the SEC yet.
What were Lineage Cell Therapeutics, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Lineage Cell Therapeutics, Inc. reported revenue of $1.1M and net income of $1.5M. The figures come from its filing with the SEC.
Is Lineage Cell Therapeutics, Inc.'s revenue growing?
Revenue in Q2 FY2026 was $1.1M, down 61.3% from $2.8M in the same quarter a year earlier.
Get an email when LCTX reports
Follow LCTX and we email you its next results the day they are filed, with the numbers explained.